UNI-EN 7:SHAREHOLDERS REPRESENTING MORE THAN FIVE PERCENT OF THE VOTES AT THE EXTRAORDINARY GENERAL MEETING OF THE SHAREHOLDERS HELD ON 30 NOVEMBER 2011
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 7 | / | 2011 | | ||||||
| Date of issue: | 2011-12-05 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| SHAREHOLDERS REPRESENTING MORE THAN FIVE PERCENT OF THE VOTES AT THE EXTRAORDINARY GENERAL MEETING OF THE SHAREHOLDERS HELD ON 30 NOVEMBER 2011 | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 70 pkt 3 Ustawy o ofercie - WZA lista powyżej 5 % | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| The Board of Directors of SOPHARMA AD (the “Company") hereby announces that the following shareholders held more than five percent of the total votes represented at the extraordinary general meeting of the shareholders of the Company (the “EGM") held on 30 November 2011: • TELEKOMPLEKT AD held 26,948,052 votes, constituting 27.42% of the votes represented at the EGM and 20.42% of the total votes in the Company; • FINANCIAL CONSULTANCY COMPANY AD held 21,440,855, constituting 21.82% of the votes represented at the EGM and 16.24% of the total votes in the Company; • DONEV INVESTMENTS HOLDING AD, held 32,417,642 votes, constituting 32.99% of votes represented at the EGM and 24.56% of total votes in the Company. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | nd | ||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2011-12-05 | Ognian Donev | Chairman of the Board of Directors | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to None PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
